SCHEMBL14922899

SCHEMBL14922899

CC[C@@H]1CCC(C=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6083462 1.00
SCHEMBL11796470 0.86 ADH1A (0.39)
SCHEMBL2911954 0.85 ALDH1A1 (0.33)
SCHEMBL21476640 0.85 ALDH1A1 (0.33)
SCHEMBL11329643 0.85 ALDH1A1 (0.33)
SCHEMBL11834254 0.85 ADH1A (0.42)
SCHEMBL1425939 0.82
SCHEMBL14533780 0.82
SCHEMBL12804871 0.80 ADH1B (0.34)
SCHEMBL12806026 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013064703-A9 FKBP SUBTYPE-SPECIFIC RAPAMYCIN ANALOGUE FOR USE IN TREATMENT OF DISEASES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2013-06-27 WO disclosed
WO-2013064703-A2 FKBP SUBTYPE-SPECIFIC RAPAMYCIN ANALOGUE FOR USE IN TREATMENT OF DISEASES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2013-05-10 WO disclosed
EP-2589383-A1 FKBP subtype-specific rapamycin analogue for use in treatment of diseases Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin (DE) 2013-05-08 EP disclosed